LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 82.01 | 27.76 | 9504 | 7000 | 1.3576 | 1.0781 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 82.01 | 27.76 | 1142 | 7000 | 0.1631 | 0.5934 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 82.01 | 27.76 | 11160 | 7000 | 1.5942 | 1.1204 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 83.72 | 27.76 | 428 | 7055 | 0.0607 | 0.4083 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 83.72 | 27.76 | 9694 | 7055 | 1.3739 | 1.0811 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 83.72 | 27.76 | 1084 | 7055 | 0.1536 | 0.5820 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 83.72 | 27.76 | 11411 | 7055 | 1.6173 | 1.1240 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 85.42 | 27.76 | 447 | 7025 | 0.0636 | 0.4164 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 85.42 | 27.76 | 9940 | 7025 | 1.4148 | 1.0888 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 85.42 | 27.76 | 1014 | 7025 | 0.1443 | 0.5694 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 85.42 | 27.76 | 11603 | 7025 | 1.6515 | 1.1297 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 87.13 | 27.76 | 440 | 6987 | 0.0630 | 0.4140 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 87.13 | 27.76 | 10115 | 6987 | 1.4475 | 1.0949 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 87.13 | 27.76 | 1040 | 6987 | 0.1488 | 0.5751 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 87.13 | 27.76 | 11846 | 6987 | 1.6952 | 1.1368 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 88.84 | 27.76 | 437 | 6965 | 0.0627 | 0.4131 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 88.84 | 27.76 | 10370 | 6965 | 1.4889 | 1.1024 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 88.84 | 27.76 | 1060 | 6965 | 0.1522 | 0.5793 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 88.84 | 27.76 | 12155 | 6965 | 1.7452 | 1.1447 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 90.55 | 27.76 | 432 | 6928 | 0.0623 | 0.4115 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 90.55 | 27.76 | 10616 | 6928 | 1.5322 | 1.1101 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 90.55 | 27.76 | 1077 | 6928 | 0.1554 | 0.5831 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 90.55 | 27.76 | 12445 | 6928 | 1.7961 | 1.1526 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 92.25 | 27.76 | 476 | 6873 | 0.0693 | 0.4296 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 92.25 | 27.76 | 10897 | 6873 | 1.5854 | 1.1193 | MN20160318_Q01 | E21 |